Sunday, September 7, 2025

Common allergy spray slashes COVID-19 risk in surprising trial

A common hay fever nasal spray was found to cut COVID-19 infections by two-thirds in a clinical trial, while also reducing rhinovirus cases. Researchers believe it could serve as an easy, low-cost preventive measure, pending further studies.

from Top Health News -- ScienceDaily https://ift.tt/fDmxMdH

No comments:

Post a Comment

This AI knew the answers but didn’t understand the questions

For decades, psychologists have debated whether the human mind can be explained by one unified theory or must be broken into separate parts ...